Early Oropharyngeal cancer and screening in Gay and Bisexual Men
男同性恋和双性恋男性的早期口咽癌和筛查
基本信息
- 批准号:10627224
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAfricaAfrica South of the SaharaAfricanAnusAreaAssessment toolAttitudeBeliefBisexualCancer EtiologyCancer InterventionCellular PhoneCervical Cancer ScreeningCessation of lifeCitiesCohort StudiesDataDiagnosisDisease ProgressionEarly DiagnosisEducational CurriculumEducational process of instructingEffectivenessEnrollmentEpidemicEvaluationExhibitsFundingFutureGaysGeneral PopulationHIV/STDHPV-High RiskHealthHigh PrevalenceHomosexualityHuman Papilloma Virus VaccinationHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16IncidenceIndividualInfectionInstitutional Review BoardsInstructionInternetInterventionKnowledgeLesionMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of anusMalignant neoplasm of cervix uteriMediatingNeeds AssessmentNotificationOralOropharyngealParentsParticipantPersonsPharyngeal structurePopulationPublicationsQuestionnairesResearchResolutionRiskScheduleScreening for cancerSecondary PreventionSeedsSelf AssessmentSeriesSeveritiesSexual HealthSiteSpecialistStigmatizationStudentsSurveysSwabTanzaniaTestingThroat CancerTimeTrainingUnited States National Institutes of HealthVaccinatedVaccinationVisitWomanWorkacceptability and feasibilitycancer riskearly screeningfirewallfollow-uphealth disparityhigh riskinterestlow and middle-income countrieslow income countrymalignant oropharynx neoplasmmenmetropolitanparent grantpreventrecruitresponsescreeningsexual minority menvaccine acceptance
项目摘要
Abstract
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as “NOT-CA-
22-057”. High-risk HPV (hrHPV) is a major transmissible cause of cancers of the anus and oropharynx in
sexual minority men (SMM). Prevalence of hrHPV in SMM in Tanzania, East Africa, a LMIC, is high and
probably epidemic in its largest metropolitan area, Dar es Salaam. We propose to replicate our study to invite
and train Tanzanian SMM to take “selfies” of the oropharynx at sufficiently high resolution to observe potential
early lesions that may be malignant. These “selfies” are rated by an expert on oropharyngeal cancer for
sufficient clarity to detect early lesions. A group of 100 SMM will be recruited by both Internet and RDS seeds
to participate in the study, and also offered a full course of hrHPV vaccination. An initial questionnaire on
knowledge, attitudes and sexual practices will be completed on Internet and participants trained at a local NGO
to take oral “selfies” which are uploaded to a firewalled Internet site for an ENT specialist to assess clarity.
After enrollment, two further visits will be scheduled at 2 and 6 months for vaccination shots, and to assess
retention for a future cohort study. Data on knowledge, attitudes, sexual risk practices, acceptability and
feasibility of screening for oropharyngeal cancer, and hrHPV vaccination, in this population and setting will be
assessed.
摘要
本申请是为了响应被标识为“NOT-CA-”的特别利益通知(NOSI)而提交的。
22-057”。高危型HPV(hrHPV)是导致肛门癌和口咽癌的主要传染性原因,
性少数男性(SMM)在东非坦桑尼亚的SMM中,hrHPV的流行率很高,
可能在其最大的都会区达累斯萨拉姆流行。我们建议复制我们的研究,
并训练坦桑尼亚SMM以足够高的分辨率拍摄口咽部的“自拍”,
早期病变可能是恶性的。这些“自拍照”被一位口咽癌专家评为
足够的清晰度来检测早期病变。互联网和RDS种子将招募100名SMM
参与研究,并提供了一个完整的hrHPV疫苗接种过程。初步调查表,
知识、态度和性行为将在因特网上完成,参加者将在当地一个非政府组织接受培训
拍摄口腔“自拍”,然后上传到一个有防火墙的网站上,供耳鼻喉科专家评估清晰度。
入组后,将在2个月和6个月时安排两次进一步访视,以进行疫苗接种,并评估
保留用于未来的队列研究。关于知识、态度、性风险做法、可接受性和
在这一人群和环境中进行口咽癌筛查和hrHPV疫苗接种的可行性,
评估。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oral/oropharyngeal "selfies" in gay and bisexual men: a pilot study exploring oropharyngeal screening for HPV-related possible malignancies.
- DOI:10.3389/fpubh.2023.1233274
- 发表时间:2023
- 期刊:
- 影响因子:5.2
- 作者:Ross, Michael W.;Bennis, Sarah L.;Nichols, C. Mark;Zoschke, I. Niles;Wilkerson, J. Michael;Rosser, B. R. Simon;Stull, Cyndee L.;Nyitray, Alan G.;Flash, Charlene;Khariwala, Samir S.
- 通讯作者:Khariwala, Samir S.
HPV-related oropharyngeal cancer early detection in gay and bisexual men is an "orphan" practice: A qualitative analysis among healthcare providers.
- DOI:10.3389/fpubh.2023.1165107
- 发表时间:2023
- 期刊:
- 影响因子:5.2
- 作者:Zoschke, I. Niles;Bennis, Sarah L.;Wilkerson, J. Michael;Stull, Cynthia L.;Nyitray, Alan G.;Khariwala, Samir S.;Nichols, C. Mark;Rosser, B. R. Simon;Flash, Charlene;Ross, Michael W.
- 通讯作者:Ross, Michael W.
Screening for HPV-Related Oropharyngeal Cancer in Gay and Bisexual Men: Acceptability and Predicting Possible Use of "Oral Selfies" by Smartphone as a Secondary Prevention Approach.
男同性恋和双性恋男性中 HPV 相关口咽癌的筛查:智能手机“口腔自拍”作为二级预防方法的可接受性和预测可能的使用。
- DOI:10.3390/venereology2040016
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Ross,MichaelW;Bennis,SarahL;Zoschke,Niles;SimonRosser,BrianR;Stull,CyndeeL;Nyitray,AlanG;Khariwala,SamirS;Nichols,Mark;Flash,Charlene;Wilkerson,Michael
- 通讯作者:Wilkerson,Michael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W ROSS其他文献
MICHAEL W ROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W ROSS', 18)}}的其他基金
HPV Oropharyngeal cancer and screening in Gay and Bisexual Men
男同性恋和双性恋男性的 HPV 口咽癌和筛查
- 批准号:
10179342 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
HPV Oropharyngeal cancer and screening in Gay and Bisexual Men
男同性恋和双性恋男性的 HPV 口咽癌和筛查
- 批准号:
10421060 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
HIV, Risk Behaviors, and Stigma in High Risk Tanzanian Men
坦桑尼亚高危男性的艾滋病毒、危险行为和耻辱
- 批准号:
7929410 - 财政年份:2010
- 资助金额:
$ 20万 - 项目类别:
HIV, Risk Behaviors, and Stigma in High Risk Tanzanian Men
坦桑尼亚高危男性的艾滋病毒、危险行为和耻辱
- 批准号:
8128462 - 财政年份:2010
- 资助金额:
$ 20万 - 项目类别:
Measuring Oral Disease Burden for Planning Services
衡量口腔疾病负担以提供规划服务
- 批准号:
6648442 - 财政年份:2002
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:














{{item.name}}会员




